← Leaderboards
Frances M. Leslie
University Of California Irvine
$5,840,846
Attributed
$5,840,846
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $638.2K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$13,644,395 · 6
By mechanism
P50$8,334,704 · 2
R01$5,309,691 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of California Irvine
Same institution · by research overlap
- Tallie Z. Z Baram$31,609,783
Others in their field
Top investigators on “Nicotine”
- Dorothy K Hatsukami · University Of Minnesota Twin Cities$52,725,890
- Stephen T Higgins · University Of Vermont &St Agric College$41,481,617
- Neal L Benowitz · University Of California San Francisco$28,140,951
- Caryn Lerman · University Of Southern California$26,022,644
- Stephen S Hecht · University Of Minnesota$25,906,702
- Marina R. Picciotto · Yale University$25,752,267
Research focus
NicotineIn Situ HybridizationDrug AddictionNicotinic ReceptorsMature AnimalSelf AdministrationPharmaceutical PreparationsTobaccoRattusResponseEvaluationLaboratory RatDoseSalineBehavioralAdultAnimalsChronicAge DifferenceLaboratory MouseBehavior TestGenetic SusceptibilityGenetically Modified AnimalsTobacco Abuse
Grant awards (25)
The role of non-nicotine tobacco smoke constituents in withdrawal and craving$337,214
R01 · FY2018 · DA · contact PI
The role of non-nicotine tobacco smoke constituents in withdrawal and craving$337,804
R01 · FY2017 · DA · contact PI
The role of non-nicotine tobacco smoke constituents in withdrawal and craving$334,976
R01 · FY2016 · DA · contact PI
The role of non-nicotine tobacco smoke constituents in withdrawal and craving$334,933
R01 · FY2015 · DA · contact PI
Mechanisms of Adolescent Vulnerability to Drugs of Abuse$278,288
R01 · FY2008 · DA · contact PI
Role of Monoamine Oxidases in Tobacco Addiction$248,523
R01 · FY2008 · DA · contact PI
Role of Monoamine Oxidases in Tobacco Addiction$254,143
R01 · FY2007 · DA · contact PI
Mechanisms of Adolescent Vulnerability to Drugs of Abuse$248,114
R01 · FY2007 · DA · contact PI
Mechanisms of Adolescent Vulnerability to Drugs of Abuse$36,849
R01 · FY2007 · DA · contact PI
Role of Monoamine Oxidases in Tobacco Addiction$262,243
R01 · FY2006 · DA · contact PI
Mechanisms of Adolescent Vulnerability to Drugs of Abuse$255,877
R01 · FY2006 · DA · contact PI
Nicotine Regulation of Developing Brain Catecholamines$376,000
R01 · FY2005 · DA
Mechanisms of Adolescent Vulnerability to Drugs of Abuse$262,215
R01 · FY2005 · DA
Nicotine Regulation of Developing Brain Catecholamines$376,000
R01 · FY2004 · DA
Mechanisms of Adolescent Vulnerability to Drugs of Abuse$260,553
R01 · FY2004 · DA
CENTER ON TOBACCO USE SUSCEPTIBILITY AND INTERVENTION$2,003,145
P50 · FY2003 · DA
Nicotine Regulation of Developing Brain Catecholamines$376,000
R01 · FY2003 · DA
CENTER ON TOBACCO USE SUSCEPTIBILITY AND INTERVENTION$2,020,771
P50 · FY2002 · DA
Nicotine Regulation of Developing Brain Catecholamines$372,373
R01 · FY2002 · DA
ANIMAL MODELS OF NICOTINE SUSCEPTIBILITY$179,222
P50 · FY2002 · DA
CENTER ON TOBACCO USE SUSCEPTIBILITY AND INTERVENTION$1,829,477
P50 · FY2001 · DA
Nicotine Regulation of Developing Brain Catecholamines$357,586
R01 · FY2001 · DA
ANIMAL MODELS OF NICOTINE SUSCEPTIBILITY$179,222
P50 · FY2001 · DA
CENTER ON TOBACCO USE SUSCEPTIBILITY AND INTERVENTION$1,950,156
P50 · FY2000 · DA
ANIMAL MODELS OF NICOTINE SUSCEPTIBILITY$172,711
P50 · FY2000 · DA